Retatrutide 10mg
Retatrutide 20mg
Retatrutide is an investigational once-weekly injectable synthetic peptide being developed by Eli Lilly for weight loss and type 2 diabetes. As a "triple agonist," it stimulates three receptors (GLP-1, GIP, and Glucagon) to suppress appetite, slow digestion, and boost metabolism. Phase 3 trial results showed an average body weight reduction of up to 28%
